Vendor review
Peptide-S reviews
Peptide-S reviews from 134 independent lab tests (Retatrutide, Tirzepatide and Tesamorelin): grade A, purity and fill accuracy. Is Peptide-S legit? See what its vials showed.
Grade A134 independent lab tests0 peptides listedTrustpilot 3.7/5 (3 reviews)Ships from United StatesVisit website
What the lab tests show
134 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 8, 2026 | Tesamorelin | 99.9 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 10 mg | Fail | View | |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 55.6 mg of 60 mg (-7 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.6 % | 5.6 mg of 5 mg (12 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 13.4 mg of 20 mg (-33 %) | Pass | View |
| Aug 3, 2026 | Tesamorelin | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Mar 2, 2026 | Tirzepatide | 99.9 % | 20 mg of 20 mg (0 %) | Pass | View |
| Mar 2, 2026 | Tirzepatide | 99.9 % | 35.2 mg of 30 mg (17 %) | Pass | View |
| Mar 2, 2026 | Tirzepatide | 99.9 % | 56.3 mg of 60 mg (-6 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.9 % | 41 mg of 40 mg (2 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.41 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Feb 22, 2026 | GHK-Cu | 99.76 % | 100 mg of 100 mg (0 %) | Pass | View |
| Feb 20, 2026 | Sermorelin | 98.7 % | 4.58 mg of 5 mg (-8 %) | Pass | View |
| Feb 20, 2026 | Ipamorelin | 99.86 % | 5.1 mg of 5 mg (2 %) | Pass | View |
| Feb 15, 2026 | Retatrutide | 99.7 % | 14.7 mg of 20 mg (-27 %) | Pass | View |
| Feb 13, 2026 | Tirzepatide | 99.9 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Feb 11, 2026 | Tirzepatide | 99.5 % | 27.8 mg of 30 mg (-7 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.8 % | 21.4 mg of 20 mg (7 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.6 % | 34.8 mg of 30 mg (16 %) | Pass | View |
| Jan 15, 2026 | Semaglutide | 99.8 % | 6 mg of 5 mg (20 %) | Pass | View |
| Jan 15, 2026 | Tesamorelin | 97.18 % | 7.97 mg of 10 mg (-20 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.7 % | 32.5 mg of 30 mg (8 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.69 % | 32.7 mg of 30 mg (9 %) | Pass | View |
| Jan 1, 2026 | Retatrutide | 99.7 % | 33.1 mg of 30 mg (10 %) | Pass | View |
| Dec 18, 2025 | Tirzepatide | 99.8 % | 35 mg of 30 mg (17 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.7 % | 33.9 mg of 30 mg (13 %) | Pass | View |
| Dec 13, 2025 | Tirzepatide | 99.7 % | 55.9 mg of 50 mg (12 %) | Pass | View |
| Nov 25, 2025 | Cagrilintide | 98.62 % | 5.39 mg of 5 mg (8 %) | Pass | View |
| Nov 25, 2025 | Survodutide | 99.87 % | 8.21 mg of 10 mg (-18 %) | Pass | View |
| Nov 25, 2025 | Mazdutide | 98.74 % | 9.31 mg of 10 mg (-7 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 20 mg | Fail | View | |
| Nov 7, 2025 | GHK-Cu | 99.967 % | 60.35 mg of 50 mg (21 %) | Pass | View |
| Nov 4, 2025 | Retatrutide | 99.6 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Oct 24, 2025 | Retatrutide | 99.5 % | 10 mg of 10 mg (0 %) | Pass | View |
| Oct 24, 2025 | Tirzepatide | 99.5 % | 5.2 mg of 5 mg (4 %) | Pass | View |
| Oct 13, 2025 | Retatrutide | 99 % | 5.4 mg of 5 mg (8 %) | Pass | View |
| Oct 9, 2025 | Tesamorelin | 93.19 % | 4.89 mg of 5 mg (-2 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 98.94 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
| Sep 30, 2025 | Retatrutide | 99.95 % | 18.7 mg of 20 mg (-7 %) | Pass | View |
| Sep 18, 2025 | Retatrutide | 99.94 % | 30.7 mg of 20 mg (54 %) | Pass | View |
| Sep 18, 2025 | Tirzepatide | 99.95 % | 13.1 mg of 10 mg (31 %) | Pass | View |
| Sep 18, 2025 | Ipamorelin | 99.92 % | 4.31 mg of 5 mg (-14 %) | Pass | View |
| Sep 18, 2025 | BPC-157 | 5 mg | Fail | View | |
| Sep 13, 2025 | Tesamorelin | 99.889 % | 5.23 mg of 5 mg (5 %) | Pass | View |
| Sep 9, 2025 | Retatrutide | 99.915 % | 56.28 mg of 50 mg (13 %) | Pass | View |
| Sep 4, 2025 | Retatrutide | 99.92 % | 18.8 mg of 20 mg (-6 %) | Pass | View |
| Sep 4, 2025 | Retatrutide | 10 mg | Fail | View | |
| Sep 4, 2025 | Tirzepatide | 99.83 % | 31.5 mg of 30 mg (5 %) | Pass | View |
| Sep 4, 2025 | Retatrutide | 99.85 % | 13.7 mg of 15 mg (-9 %) | Pass | View |
| Sep 4, 2025 | Tirzepatide | 99.84 % | 56.7 mg of 60 mg (-5 %) | Pass | View |
| Sep 4, 2025 | Tirzepatide | 99.95 % | 9.96 mg of 10 mg (0 %) | Pass | View |
| Sep 4, 2025 | Tirzepatide | 99.86 % | 9.67 mg of 10 mg (-3 %) | Pass | View |
| Sep 4, 2025 | Tirzepatide | 99.93 % | 13.8 mg of 15 mg (-8 %) | Pass | View |
| Sep 4, 2025 | BPC-157 | 99.95 % | 9.82 mg of 10 mg (-2 %) | Pass | View |
| Aug 31, 2025 | Retatrutide | 99.95 % | 9.64 mg of 10 mg (-4 %) | Pass | View |
| Aug 31, 2025 | Tirzepatide | 99.74 % | 60 mg of 60 mg (0 %) | Pass | View |
| Aug 31, 2025 | BPC-157 | 99.79 % | 4.96 mg of 5 mg (-1 %) | Pass | View |
| Aug 21, 2025 | Retatrutide | 99.85 % | 9.77 mg of 10 mg (-2 %) | Pass | View |
What Peptide-S sells
No current listings on record.
About Peptide-S
Finnrick has tested 134 samples from Peptide-S across 11 products.